UL Knowledge Transfer Office – UL Knowledge Transfer Office

Festival UNI.MINDS successfully wrapped! #innovatetogether See what you missed!

Researchers

Disclose your invention

Companies

What we offer

Students

I have an idea. What to do next?

University of Ljubljana
in numbers

0

researchers

0

patent applications

0

million € in market revenue

Latest news

2. February, 2023

ONLINE WORKSHOP: University-Industry cooperation from the industrial point of view

The aim of this hands-on training is to empower researchers and PhD students with…

28. December, 2022

Happy 2023!

This year, we have created moments of learning (the conference for successful commercialization of…

15. November, 2022

The winners of the 3rd UL Innovation Fund have been announced!

Rector of the University of Ljubljana, dr. Gregor Majdič, announced the recipients of this…

11. November, 2022

Thank you for being part of UNI.MINDS 2022!

The UNI.MINDS festival took place from 8th to 10th November 2022 and featured more…

More news

Latest technologies

Method for noninvasive diagnosis of endometriosis

Background Endometriosis (ICD-10 N80) is a complex, benign neoplastic, gynecological disease with ectopic growth of endometrium-like tissue that affects around 170 million women worldwide; around 40,000 new cases are observed annually only in Germany. It manifests itself with dysmenorrhea, dyspareunia and chronic pelvic pain up to infertility. There are three…

Novel quinolin-2-yl nitrones useful for the prevention and/or treatment of neurodegenerative diseases

Background Alzheimer’s disease is a neurodegenerative disease characterized by progressive deterioration of memory and learning ability due to a variety of pathological changes in the central nervous system. Parkinson’s disease is a chronic neurodegenerative disease characterized by the progressive death of dopaminergic neurons. Due to the aging of the population,…

Compressible and free flowing co-processed mesoporous silica for the production of amorphous solid dispersions containing active pharmaceutical ingredient

Background Single unit dosage forms suitable for oral administration of the active pharmaceutical ingredients are usually formulated in the form of solid formulations. In addition to the active pharmaceutical ingredients, these forms, tablets and capsules, contain pharmaceutically acceptable substances called excipients, which are not active and have no therapeutic effect….

More technologies